EMA — authorised 18 March 1998
- Marketing authorisation holder: ViiV Healthcare BV
- Status: approved
🇪🇺 Retrovir in European Union
EMA authorised Retrovir on 18 March 1998
Marketing authorisation
Retrovir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Retrovir approved in European Union?
Yes. EMA authorised it on 18 March 1998.
Who is the marketing authorisation holder for Retrovir in European Union?
ViiV Healthcare BV holds the EU marketing authorisation.